Drug Profile
Research programme: obesity therapy - Rinat Neuroscience
Alternative Names: RN-450Latest Information Update: 12 May 2006
Price :
$50
*
At a glance
- Originator Rinat Neuroscience
- Class
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Obesity
Most Recent Events
- 12 May 2006 No development reported - Preclinical for Obesity in USA (unspecified route)
- 15 Apr 2005 Preclinical trials in Obesity in USA (unspecified route)